It has been demonstrated that the PI3K utilizes AKT-dependent and AKT-independent pathway in activating estrogen receptor α (ERα) in breast cancer cells and it could help the cancer cells to escape from tamoxifen-induced apoptosis [48]. Here, ESR1 is linked to cancer.